Hopefully you're right but still in a bit in shock about
Hopefully you're right but still in a bit in shock about this 10K. All of my fellow investors that I brought on board are freaking out. The ones who sold after the first Mako article smirk with pity as I continue to talk up IPIX year after year after year at gatherings - the ramblings of a madman it seems. Unfortunately this investment seemed to be a multi-pronged drug portfolio with lots of security and paths forward. As of this week it appears to have become a binary bet on a partnership.
With success of signing a deal we will make it out alive. With both OM and IBD in play the deal size could be very large if the pharma partner chooses not to put the screws to us due to our weak financial position.
With failure to sign a deal we likely face ruinous dilution to move forward, auction at firesale rates or worse.
I have already lost so much that I steeled my resolve and simply consider it a very large tax write-off with a gigantic upside potential. If I lose the remaining $0.25 it will suck but I already am assuming that. If I sold now and a megadeal was signed just after I gave up it would bother me for the rest of my days that the Mako crew got the best of me.
We have no good way of determining the likelihood of success in this deal making. Company guidance for the past year has been unreliable as a tool for predicting when/if certain things will happen. This whole investment has been nothing more than a losing night at the casino for years on end. We've been kicked out of the high-stakes room and we're looking at one last pull of the handle on the slot machine. If feel all our hopes rest on one last quarter (both time wise and shareprice wise).
Bring it home for us Leo. For the shareholders, for the patients, and for yourself. Don't let this fall through. So many are counting on you! Make all the detractors eat crow and burn those shorts!
1
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Legal Rigmarole The market's got its knickers in a twist over AST SpaceMobile, folks. If you've been dabbling in NASDAQ:ASTS between March '25 and mid-July '26, it's time to perk up those ears. The legal eagles at Robbins Geller Rudman & Dowd LLP are rallying the troops for a class action lawsuit with you front and center. Deadline's looming on November 13, 2026, for...
Continue Reading
Trading Freight Train Gains Speed Trading is on the upswing, my friends. What good ol' intuition and the headlines tell us, numbers reflect: more retail investors are jumping into the fray, and the brokers are soaking it up. We're eyeing some hefty figures, like a market swell from $11.97 billion in 2025 to a projected $18.29 billion by 2030. That's an 8.9% growth...
Continue Reading
Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...
Continue Reading
Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...
Continue Reading
Holiday Transformation at SeaWorld's Parks The holiday spirit isn't something you purchase—it’s an experience. And boy, SeaWorld seems to get this right. As the chill of late October settles in, SeaWorld parks across Orlando, San Diego, and San Antonio start dressing up for the holiday season, morphing into a spectacle of lights and festive joy. For anyone who’s...
Continue Reading
The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...
Continue Reading
Maison Martell Dances to a New Beat The world's oldest cognac house, Maison Martell, is mixing things up in a way that’ll make your typical whiskey-on-the-rocks seem like child’s play. They've snagged Afrobeat heavyweight Davido and renowned visual poet Prince Gyasi to spin a fresh narrative, one where melody and imagery play in harmony. While this ain't your usual...
Continue Reading
Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...
Continue Reading
Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...
Continue Reading
Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...
Continue Reading
Top 5 Most Recently Viewed Articles
EQT Real Estate's Historic Industrial Transaction EQT Real Estate is proud to announce the completion of a significant transaction involving the sale of a logistics portfolio totaling 8.7 million square feet across 25 properties. This remarkable sale has become a landmark achievement in the U.S. industrial market, marking one of the largest transactions of its kind to...
Continue Reading
Harvia's Financial Insights for Half-Year 2025 Harvia Plc is gearing up to unveil its financial performance for the first six months of 2025. The half-year report is set to be released on Thursday at approximately 9:00 a.m. EEST. This event is highly anticipated by investors and analysts alike, showcasing the company's commitment to transparency and engagement. A Look at...
Continue Reading
Regeneron Takes Action Against Ebola with Inmazeb Donation Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is recognized as a groundbreaking treatment approved by the U.S. Food and Drug Administration (FDA) for the Ebola infection caused by Orthoebolavirus zairense, commonly known as Zaire ebolavirus. Currently, supply efforts are accelerating to help address the...
Continue Reading
Stock Market Overview The U.S. stock market experienced a positive surge, with key indices showing significant gains. The Dow Jones index climbed over 100 points recently, reflecting a robust trading environment. Market Performance After the market opened, the Dow surged by 0.27%, reaching 42,290.97. Concurrently, NASDAQ achieved a rise of 0.16% to 18,218.51, while the...
Continue Reading
Understanding the Investigation into Hasbro, Inc. Faruqi & Faruqi, LLP, a distinguished national securities law firm, has taken a pivotal step to assist investors who might have suffered losses over $100,000 due to issues surrounding Hasbro, Inc. (NASDAQ: HAS). The firm is eager to connect with those impacted to discuss their potential legal options. If you are among the...
Continue Reading